Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Herit...
FDA Drug Recall #D-1626-2020 — Class III — September 24, 2020
Recall Summary
| Recall Number | D-1626-2020 |
| Classification | Class III — Low risk |
| Date Initiated | September 24, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Legacy Pharmaceutical Packaging LLC |
| Location | Earth City, MO |
| Product Type | Drugs |
| Quantity | 111,948 bottles |
Product Description
Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, Distributed by: Wal-Mart, Bentonville, AR 72716. NDC 68645-545-59
Reason for Recall
Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
Distribution Pattern
Walmart distribution centers in GA and AR
Lot / Code Information
Lot #: 201626, Exp. Date 08/2022
Other Recalls from Legacy Pharmaceutical Packaging LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0205-2024 | Class II | Sertraline Tablets, USP 100 mg, 30 tablets per ... | Dec 11, 2023 |
| D-1263-2019 | Class II | Losartan Potassium Tablets, USP, 50 mg, 30 tabl... | Apr 24, 2019 |
| D-1050-2019 | Class II | Losartan Potassium Tablets, USP, 100 mg, 30 tab... | Mar 1, 2019 |
| D-1075-2019 | Class II | Losartan Potassium Tablets, USP, 50 mg, 30 tabl... | Mar 1, 2019 |
| D-1048-2019 | Class II | Losartan Potassium Tablets, USP, 25 mg, 30 tabl... | Mar 1, 2019 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.